Physician

Christopher M Mcclinton, M.D.

According to 2025 Medicare claims, Christopher Mcclinton, M.D. (NPI: 1144586280) practices radiation oncology in the Fayetteville-Springdale-Rogers, AR market, with the plurality of this provider's patient population coming from Washington, AR. This provider's primary affiliated billing organization is HIGHLANDS ONCOLOGY GROUP PA (NPI: 1346211323; TIN: 710788742) and primary practice location at 72758-8602.

Mcclinton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 551 traditional Medicare patients, billed 6,247 HCPCS/CPT codes, and received $1,141,136 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 168 prescription claims across 93 beneficiaries totaling $3,368 in drug costs, led by Dexamethasone (Dexamethasone). Open Payments data shows 25 records totaling $787. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $379,432 to $1,141,136. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,849 and ending at $3,368. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	197	2,752	$379,432
2018	375	5,529	$768,089
2019	420	7,609	$982,816
2020	386	5,425	$1,034,819
2021	384	5,952	$1,265,316
2022	442	10,712	$1,506,595
2023	459	5,828	$981,733
2024	551	6,247	$1,141,136

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	27	59	$2,849
2016	15	24	$1,018
2017	19	33	$731
2018	56	120	$2,818
2019	81	174	$3,845
2020	65	124	$2,587
2021	51	104	$1,804
2022	62	109	$2,451
2023	76	154	$3,441
2024	93	168	$3,368

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	269	1,145	$239
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	117	117	$158
77334	Design and construction of complex radiation treatment device	111	211	$88
77014	Ct guidance for insertion of radiation therapy fields	218	1,402	$83
77336	Continuing radiation therapy consultation per week	115	355	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dexamethasone	Dexamethasone	24	570	$561
Tamsulosin Hcl	Tamsulosin Hcl	37	1,404	$172
Ondansetron Odt	Ondansetron	12	117	$131
Levofloxacin	Levofloxacin	12	66	$32

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	25	$787	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher M. Mcclinton, M.D.?

Tedicare shows public-source Medicare data for Christopher M. Mcclinton, M.D. (NPI 1144586280), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher M. Mcclinton, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher M. Mcclinton, M.D.?

Christopher M. Mcclinton, M.D. is linked to HIGHLANDS ONCOLOGY GROUP PA (billing NPI 1346211323) in the available physician profile data.

Does Christopher M. Mcclinton, M.D. have Open Payments data?

Christopher M. Mcclinton, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.